According to guidelines, what is the evidence for using weight loss medications as monotherapy in pediatric obesity?

• A. There is strong evidence supporting monotherapy
• B. No current evidence supports weight loss medication use as monotherapy
• C. Monotherapy is recommended after lifestyle changes
• D. Monotherapy is preferred over behavioral interventions

Answer: (B)

This item tests whether weight loss medications have evidence as a stand-alone, or monotherapy, treatment in children and teens. In pediatric obesity, the foundation of treatment is intensive lifestyle modification and behavioral support. Medications are considered only as an additional aid to a comprehensive weight-management plan, not as a replacement for lifestyle changes. There isn’t solid evidence showing that using a weight loss drug alone leads to meaningful or durable weight loss in youths, and safety concerns with long-term use in developing children further limit monotherapy use. Therefore, there is no current evidence to support treating pediatric obesity with weight loss medications as monotherapy.